Journal
JOURNAL OF IMMUNOLOGY
Volume 178, Issue 9, Pages 5443-5453Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.178.9.5443
Keywords
-
Categories
Funding
- NCI NIH HHS [T32 CA 009429, R01 CA 057436] Funding Source: Medline
- NIAID NIH HHS [R01 AI 059676] Funding Source: Medline
Ask authors/readers for more resources
Pre-TCR signals regulate the transition of the double-negative (DN) 3 thymocytes to the DN4, and subsequently to the double-positive (DP) stage. In this study, we show that pre-TCR signals activate Akt and that pharmacological inhibition of the PI3K/Akt pathway, or combined ablation of Akt1 and Akt2, and to a lesser extent Akt1 and Akt3, interfere with the differentiation of DN3 and the accumulation of DP thymocytes. Combined ablation of Akt1 and Akt2 inhibits the proliferation of DN4 cells, while combined ablation of all Akt isoforms also inhibits the survival of all the DN thymocytes. Finally, the combined ablation of Akt1 and Akt2 inhibits the survival of DP thymocytes. Constitutively active Lck-Akt1 transgenes had the opposite effects. We conclude that, following their activation by pre-TCR signals, Akt1, Akt2, and, to a lesser extent, Akt3 promote the transition of DN thymocytes to the DP stage, in part by enhancing the proliferation and survival of cells undergoing P-selection. Akt1 and Akt2 also contribute to the differentiation process by promoting the survival of the DP thymocytes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available